Advertisement

Urolithiasis

, Volume 47, Issue 1, pp 23–33 | Cite as

Calcium-sensing receptor: evidence and hypothesis for its role in nephrolithiasis

  • Giuseppe VezzoliEmail author
  • Lorenza Macrina
  • Giulia Magni
  • Teresa Arcidiacono
Invited Review

Abstract

Calcium-sensing receptor (CaSR) is a plasma-membrane G protein-coupled receptor activated by extracellular calcium and expressed in kidney tubular cells. It inhibits calcium reabsorption in the ascending limb and distal convoluted tubule when stimulated by the increase of serum calcium levels; therefore, these tubular segments are enabled by CaSR to play a substantial role in the regulation of serum calcium levels. In addition, CaSR increases water and proton excretion in the collecting duct and promotes phosphate reabsorption and citrate excretion in the proximal tubule. These CaSR activities form a network in which they are integrated to protect the kidney against the negative effects of high calcium concentrations and calcium precipitates in urine. Therefore, the CaSR gene has been considered as a candidate to explain calcium nephrolithiasis. Epidemiological studies observed that calcium nephrolithiasis was associated with polymorphisms of the CaSR gene regulatory region, rs6776158, located within the promoter-1, rs1501899 located in the intron 1, and rs7652589 in the 5′-untranslated region. These polymorphisms were found to reduce the transcriptional activity of promoter-1. Activating rs1042636 polymorphism located in exon 7 was associated with calcium nephrolithiasis and hypercalciuria. Genetic polymorphisms decreasing CaSR expression could predispose individuals to stones because they may impair CaSR protective effects against precipitation of calcium phosphate and oxalate. Activating polymorphisms rs1042636 could predispose to calcium stones by increasing calcium excretion. These findings suggest that CaSR may play a complex role in lithogenesis through different pathways having different relevance under different clinical conditions.

Keywords

Calcium nephrolithiasis Calcium-sensing receptor Claudin-14 Claudin-16 Randall’s plaque Calcium stones Gene polymorphism Hypercalciuria 

Abbreviations

PTH

Parathyroid hormone

CaSR

Calcium-sensing receptor

1,25(OH)D

1,25-dyhydroxyvitamin D

PKC

Protein kinase C

GPCR

G protein-coupled receptor

Notes

Funding

None.

Compliance with ethical standards

Conflict of interest

The authors declare no conflict of interest.

Ethical approval

All studies reported in the present article and involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments.

References

  1. 1.
    Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O, Sun A, Hediger MA, Lytton J, Hebert S (1992) Cloning and characterization of an extracellular Ca-sensing receptor from bovine parathyroid. Nature 366:575–580Google Scholar
  2. 2.
    Garrett JE, Capuano IV, Hammerland LG, Hung BC, Brown EM, Hebert SC, Nemeth EF, Fuller F (1995) Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J Biol Chem 270:12919–12925Google Scholar
  3. 3.
    Aida K, Koishi S, Tawata M, Onaya T (1995) Molecular cloning of a putative Ca-sensing receptor cDNA from human kidney. Biochem Biophys Res Commun 214:524–529Google Scholar
  4. 4.
    Kifor O, Diaz R, Butters R, Kifor I, Brown EM (1998) The Calcium-sensing receptor is localized in caveolin-rich plasma membrane domains of bovine parathyroid cells. J Biol Chem 273:21708–21713Google Scholar
  5. 5.
    Riccardi D, Kemp PJ (2012) The calcium-sensing receptor beyond extracellular calcium homeostasis: conception, development, adult physiology, and disease. Annu Rev Physiol 74:271–297Google Scholar
  6. 6.
    Vezzoli G, Terranegra A, Arcidiacono T, Biasion R, Coviello D, Syren ML, Paloschi V, Giannini S, Mignogna G, Rubinacci A, Ferraretto A, Cusi D, Bianchi G, Soldati L (2007) R990G polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria. Kidney Int 71:1155–1162Google Scholar
  7. 7.
    Grant MP, Stepanchick A, Cavanaugh A, Breitwieser GE (2011) Agonist-driven maturation and plasma membrane insertion of calcium-sensing receptors dynamically control signal amplitude. Sci Signal 4:ra78Google Scholar
  8. 8.
    Canaff L, Hendy GN (2002) Human calcium-sensing receptor gene. J Biol Chem 277:30337–30350Google Scholar
  9. 9.
    Canaff L, Hendy GN (2005) Calcium-sensing receptor gene transcription is up-regulated by the proinflammatory cytokine, interleukin-1b. J Biol Chem 280:14177–14188Google Scholar
  10. 10.
    Li X, Ma J, Shi W, Su Y, Fu X, Yang Y, Lu J, Yue Z (2016) Calcium oxalate induces renal injury through calcium-sensing receptor. Oxid Med Cell Longev 2016:5203801Google Scholar
  11. 11.
    Graca JAZ, Schepelmann M, Brennan SC, Reens J, Chang W, Yan P, Toka H, Riccardi D, Price SA (2016) Comparative expression of the extracellular calcium-sensing receptor in the mouse, rat, and human kidney. Am J Physiol Renal Physiol 310:F518–F533Google Scholar
  12. 12.
    Riccardi D, Brown EM (2010) Physiology and pathophysiology of the calcium-sensing receptor in the kidney. Am J Physiol Renal Physiol 298:F485–F499Google Scholar
  13. 13.
    Vezzoli G, Soldati L, Gambaro G (2009) Roles of calcium-sensing receptor (CaSR) in renal mineral ion transport. Curr Pharm Biotechnol 10:302–310Google Scholar
  14. 14.
    Jung J, Basile DP, Pratt JH (2011) Sodium reabsorption in the thick ascending limb in relation to blood pressure: a clinical perspective. Hypertension 57:873–879Google Scholar
  15. 15.
    Gamba G, Friedman PAF (2009) Thick ascending limb: the Na:K:Cl co-transporter, NKCC2, and the calcium-sensing receptor, CaSR. Eur J Physiol 458:61–76Google Scholar
  16. 16.
    Olinger E, Houillier P, Devuyst O (2018) Claudins: a tale of interactions in the thick ascending limb. Kidney Int 93:535–537Google Scholar
  17. 17.
    Toka HR, Al-Romaih K, Koshy JM, DiBartolo S, Kos CH, Quinn SJ, Curhan GC, Mount DB. Brown E, Pollak MR (2012) Deficiency of the calcium-sensing receptor in the kidney causes parathyroid hormone-independent hypocalciuria. J Am Soc Nephrol 23:1879–1890Google Scholar
  18. 18.
    Gong Y, Renigunta V, Himmerkus N, Zhang J, Renigunta A, Bleich M, Hou J (2012) Claudin-14 regulates renal Ca transport in response to CaSR signalling via a novel microRNA pathway. EMBO J 31:1999–2012Google Scholar
  19. 19.
    Ikari A, Okude C, Sawada H, Sasaki Y, Yamazaki Y, Sugatani J, Degawa M, Miwa M (2008) Activation of a polyvalent cation-sensing receptor decreases magnesium transport via claudin-16. Bioch Bioph Acta 1778:283–290Google Scholar
  20. 20.
    Gong Y, Hou J (2014) Claudin-14 underlies Ca-sensing receptor-mediated Ca metabolism via NFAT-microRNA-based mechanisms. J Am Soc Nephrol 25:745–760Google Scholar
  21. 21.
    Sato T, Courbebaisse M, Ide N, Fan Y, Hanai JI, Kaludjerovic J, Densmore MJ, Yuan Q, Toka HR, Pollak MR, Hou J, Lanske B (2017) Parathyroid hormone controls paracellular Ca transport in the thick ascending limb by regulating the tight-junction protein Claudin14. Proc Natl Acad Sci USA 114:E3344–E3353Google Scholar
  22. 22.
    Blankenship KA, Williams JJ, Lawrence MS, McLeish KR, Dean WL, Arthur JM (2001) The calcium-sensing receptor regulates calcium absorption in MDCK cells by inhibition of PMCA. Am J Physiol Renal Physiol 280:F815–F822Google Scholar
  23. 23.
    Yasuoka Y, Sato Y, Healy JM, Nonoguchi H, Kawahara K (2015) pH-sensitive expression of calcium-sensing receptor (CaSR) in type-B intercalated cells of the cortical collecting ducts (CCD) in mouse kidney. Clin Exp Nephrol 19:771–782Google Scholar
  24. 24.
    Bustamante M, Hasler U, Leroy V, deSeigneux M, Dimitrov M, Mordasini D, Rousselot M, Martin PY, Feraille E (2008) Calcium-sensing receptor attenuates AVP-induced aquaporin-2 expression via a calmodulin-dependent mechanism. J Am Soc Nephrol 19:109–116Google Scholar
  25. 25.
    Casare Milan,D, Fernandez R (2014) Stimulation of calcium-sensing receptor increases biochemical H-ATPase activity in mouse cortex and outer medullary regions. Can J Physiol Pharmacol 92:181–188Google Scholar
  26. 26.
    Ba J, Brown DM, Friedman PA (2004) Calcium-sensing receptor regulation of PTH-inhibitable proximal tubule phosphate transport. Am J Physiol Renal Physiol 285:F1233–F1243Google Scholar
  27. 27.
    Kestenbaum B, Glazer NL, Kottgen A, Felix GF, Hwang SJ, Liu Y, Lohman K, Kritchevsky SB, Hausman DB, Petersen AK, Gieger C, Ried JS, Meitinger T, Strom TM, Wichmann HE, Campbell H, Hayward C, Rudan I, de Boer IH, Psaty BM, Rice KM, Chen YDI, Li M, Arking DE, Boerwinkle E, Coresh J, Yang Q, Levy D, van Rooij FJA, Dehghan A, Rivadeneira F, Uitterlinden AG, Hofman A, van Duijn CM, Shlipak MG, Kao WHL, Witteman JCM, Siscovick DS, Fox CS (2010) Common genetic variants associate with serum phosphorus concentration. J Am Soc Nephrol 21:1223–1232Google Scholar
  28. 28.
    Hoenderop JG, Chon H, Gkika D, Bluyssen HA, Holstege FC, St- Arnaud R, Braam B, Bindels RJ (2004) Regulation of gene expression by dietary Ca in kidneys of 25-hydroxyvitamin D3-1 alpha-hydroxylase knockout mice. Kidney Int 65:531–539Google Scholar
  29. 29.
    Capasso G, Geibel PJ, Damiano S, Jaeger P, Richards WG, Geibel JP (2013) The calcium sensing receptor modulates fluid reabsorption and acid secretion in the proximal tubule. Kidney Int 84:277–284Google Scholar
  30. 30.
    Maiti A, Hait NC, Beckman MJ (2008) Extracellular calcium-sensing receptor activation induces vitamin D receptor levels in proximal kidney HK-2G cells by a mechanism that requires phosphorylation of p38α MAPK. J Biol Chem 283:175–183Google Scholar
  31. 31.
    Walker RW, Zhang S, Coleman-Barnett JA, Hamm LL, Hering-Smith KS (2018) Calcium receptor signaling and citrate transport. Urolithiasis.  https://doi.org/10.1007/s00240-018-1035-0 Google Scholar
  32. 32.
    Mendoza FJ, Martinez-Moreno J, Almaden Y, Rodriguez-Ortiz ME, Lopez I, Estepa JC, Henley C, Rodriguez M, Aguilera-Tejero E (2011) Effect of calcium and the calcimimetic AMG 641 on matrix-gla protein in vascular smooth muscle cells. Calcif Tissue Int 88:169–178Google Scholar
  33. 33.
    Vezzoli G, Terranegra A, Soldati L (2012) Calcium-sensing receptor gene polymorphisms in patients with calcium nephrolithiasis. Curr Opin Nephrol Hypertens 21:355–361Google Scholar
  34. 34.
    Toka HR, Pollak MR (2014) The role of the calcium-sensing receptor in disorders of abnormal calcium handling and cardiovascular disease. Curr Opin Nephrol Hypertens 23:494–501Google Scholar
  35. 35.
    Renkema KY, Velic A, Dijkman HB, Verkaart S, van der Kemp AW, Nowik M, Timmermans K, Doucet A, Wagner CA, Bindels RJ, Hoenderop JG (2009) The calcium-sensing receptor promotes urinary acidification to prevent nephrolithiasis. J Am Soc Nephrol 20:1705–1713Google Scholar
  36. 36.
    Guha M, Bankura B, Ghosh S, Pattanayak AK, Ghosh S, Pal DK, Puri A, Kundu AK, Das M (2015) Polymorphisms in CaSR and CLDN14 genes associated with increased risk of kidney stone disease in patients from the eastern part of India. PLoS One 10:e0130790–e0130714Google Scholar
  37. 37.
    O’Seaghdha CM, Yang Q, Glazer NL, Leak TS, Dehghan A, Smith AV, Kao WHL, Lohman K, Hwang SJ, Johnson AD, Hofman A, Uitterlinden AG, Chen YDI, The GEFOS Consortium, Brown EM, Siscovick DS, Harris TB, Psaty BM, Coresh J, Gudnason V, Witteman JC, Liu YM, Kestenbaum BR, Fox CS, Kottgen A (2010) Common variants in the calcium sensing receptor gene are associated with total serum calcium levels. Hum Mol Genet 19:4296–4303Google Scholar
  38. 38.
    Shakhssalim N, Kazemi B, Basiri A, Houshmand M, Pakmanesh H, Golestan B, Eilanjegh AF, Kashi AH, Kilani M, Azadvari M (2010) Association between calcium-sensing receptor gene polymorphisms and recurrent calcium kidney stone disease: a comprehensive gene analysis. Scand J Urol Nephrol 44:406–412Google Scholar
  39. 39.
    Kapur K, Johnson T, Beckmann ND, Sehmi J, Tanaka T, Kutalik Z, Styrkarsdottir U, Zhang W, Marek D, Gudbjartsson DF, Milaneschi Y, Holm H, DiIorio A, Waterworth D, Li Y, Singleton AB, Bjornsdottir US, Sigurdsson G, Hernandez DG, DeSilva R, Elliott P, Eyjolfsson GI, Guralnik JM, Scott J, Thorsteinsdottir U, Bandinelli S, Chambers J, Stefansson K, Waeber G, Ferrucci L, Kooner JS, Mooser V, Vollenweider P, Beckmann JS, Bochud M, Bergm S (2010) Genome-wide meta-analysis for serum calcium identifies significantly associated SNPs near the calcium-sensing receptor (CASR) gene. PLoS Genet 6:e1001035Google Scholar
  40. 40.
    Vezzoli G, Terranegra A, Aloia A, Arcidiacono T, Milanesi L, Mosca E, Mingione A, Spotti D, Cusi D, Hou J, Hendy GN, Soldati L (2013) Decreased transcriptional activity of calcium-sensing receptor gene promoter 1 is associated with calcium nephrolithiasis. J Clin Endocrinol Metab 98:3839–3847Google Scholar
  41. 41.
    Vezzoli G, Terranegra A, Arcidiacono T, Gambaro G, Milanesi L, Mosca E, Soldati L (2010) Calcium kidney stones are associated with a haplotype of the Calcium-sensing receptor gene regulatory region. Nephrol Dial Transpl 25:2245–2252Google Scholar
  42. 42.
    Li H, Zhang J, Long J, Shi J, Luo Y (2018) Calcium-sensing receptor gene polymorphism (rs7652589) is associated with calcium nephrolithiasis in the population of Yi nationality in Southwestern China. Ann Hum Genet.  https://doi.org/10.1111/ahg.12249 Google Scholar
  43. 43.
    Hamilton DC, Grover VK, Smith CA, Cole DEC (2009) Heterogeneous disease modeling for Hardy–Weinberg disequilibrium in case-control studies: Application to renal stones and calcium-sensing receptor polymorphisms. Ann Hum Genet 73:176–183Google Scholar
  44. 44.
    Corbetta S, Eller-Vainicher C, Filopanti M, Saeli P, Vezzoli G, Arcidiacono T, Loli P, Syren ML, Soldati L, Beck-Peccoz P, Spada A (2006) R990G polymorphism of the calcium-sensing receptor and renal calcium excretion in patients with primary hyperparathyroidism. Eur J Endocrinol 155:687–692Google Scholar
  45. 45.
    Vezzoli G, Tanini A, Ferrucci L, Soldati L, Bianchin C, Franceschelli F, Malentacchi C, Porfirio B, Adamo D, Terranegra A, Falchetti A, Cusi D, Bianchi G, Brandi ML (2002) Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. J Am Soc Nephrol 13:2517–2523Google Scholar
  46. 46.
    Ranieri M, Tamma G, Di Mise AM, Vezzoli G, Soldati L, Svelto M, Valenti G (2013) Excessive signal transduction of gain-of-function variants of the calcium-sensing receptor (CaSR) are associated with increased ER to cytosol calcium gradient. Plos One 8:e79113Google Scholar
  47. 47.
    Vezzoli G, Scillitani A, Corbetta S, Terranegra A, Dogliotti E, Guarnieri V, Arcidiacono T, Paloschi V, Rainone F, Eller-Vainicher C, Borghi L, Nouvenne A, Guerra A, Meschi T, Allegri F, Cusi D, Spada A, Cole DEC, Hendy GN, Spotti D, Soldati L (2011) Polymorphisms at the regulatory regions of the calcium-sensing receptor gene influence stone risk in primary hyperparathyroidism. Eur J Endocrinol 164:421–427Google Scholar
  48. 48.
    Vezzoli G, Scillitani A, Corbetta S, Terranegra A, Dogliotti E, Guarnieri V, Arcidiacono T, Macrina L, Mingione A, Brasacchio C, Eller-Vainicher C, Spada A, Cole DEC, Hendy GN, Spotti D, Soldati L (2015) Risk of nephrolithiasis in primary hyperparathyroidism is associated with two polymorphisms of the calcium-sensing receptor gene. J Nephrol 28:67–72Google Scholar
  49. 49.
    Masvidal L, Iniesta R, García M, Casalà C, Lavarino C, Mora J, de Torres C (2017) Genetic variants in the promoter region of the calcium-sensing receptor gene are associated with its down-regulation in neuroblastic tumors. Mol Carcinog 56:1281–1289Google Scholar
  50. 50.
    Vezzoli G, Macrina L, Rubinacci A, Spotti D, Arcidiacono T (2016) Intestinal calcium absorption among hypercalciuric patients with or without calcium kidney stones. Clin J Am Soc Nephrol 11:1450–1455Google Scholar
  51. 51.
    Oddsson A, Sulem P, Helgason H, Edvardsson VO, Thorleifsson G, Sveinbjörnsson G, Haraldsdottir E, Eyjolfsson GI, Sigurdardottir O, Olafsson I, Masson G, Holm H, Gudbjartsson DF, Thorsteinsdottir U, Indridason OS, Palsson R, Stefansson K (2015) Common and rare variants associated with kidney stones and biochemical traits. Nat Commun 6:7975Google Scholar
  52. 52.
    Khan SR (2017) Histological aspects of the “fixed-particle” model of stone formation: animal studies. Urolithiasis 45:75–87Google Scholar
  53. 53.
    Evan AP, Worcester EM, Coe FL, Williams J, Lingeman JE (2015) Mechanisms of human kidney stone formation. Urolithiasis 43(Suppl 1):S19–S32Google Scholar
  54. 54.
    Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Patterson RF, Kuo RL, Grynpas M (2003) Randall plaque of patients with nephrolithisis begins in basement membranes of thin loops of Henle. J Clin Invest 111:607–616Google Scholar
  55. 55.
    Evan AP, Lingeman JE, Coe FL, Shao Y, Parks JH, Bledsoe SB, Phillips CL, Bonsib S, Worcester EM, Sommer AJ, Kim SC, Tinmouth WW, Grynpas M (2005) Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int 67:576–591Google Scholar
  56. 56.
    Matlaga BR, Coe FL, Evan AP et al (2007) The role of Randall’s plaques in the pathogenesis of calcium stones. J Urol 177:31–38Google Scholar
  57. 57.
    Pearce SH, Williamson C, Kifor O, Bai M, Coulthard MG, Davies M, Lewis-Barned N, McCredie D, Powell H, Kendall-Taylor P, Brown EM, Thakker RV (1996) A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med 335:1115–1122Google Scholar
  58. 58.
    Wu XR (2015) Interstitial calcinosis in renal papillae of genetically engineered mouse models: relation to Randall’s plaques. Urolithiasis 43(Suppl 1):S65–S76Google Scholar
  59. 59.
    Beck L, Karaplis AC, Amizuka N, Hewson AS, Ozawa H, Tenenhouse HS (1998) Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc Natl Acad Sci USA 95:5372–5377Google Scholar
  60. 60.
    Chau H, El-Maadawy S, McKee MD, Tenenhouse HS (2003) Renal calcification in mice homozygous for the disrupted type IIa Na/Pi cotransporter gene Npt2. J Bone Miner Res 18:644–657Google Scholar
  61. 61.
    Shavit L, Jaeger P, Unwin RJ (2015) What is nephrocalcinosis? Kidney Int 88:35–43Google Scholar
  62. 62.
    Milatz S, Himmerkus N, Wulfmeyer VC, Drewell H, Mutig K, Hou J, Breiderhoff T, Müller D, Fromm M, Bleich M, Günzel D (2017) Mosaic expression of claudins in thick ascending limbs of Henle results in spatial separation of paracellular Na and Mg transport. Proc Natl Acad Sci USA 114:E219–E227Google Scholar
  63. 63.
    Breiderhoff T, Himmerkus N, Stuiver M, Mutig K, Will C, Meij IC, Bachmann S, Bleich M, Willnow TE, Müller D (2012) Deletion of claudin-10 (Cldn10) in the thick ascending limb impairs paracellular sodium permeability and leads to hypermagnesemia and nephrocalcinosis. Proc Natl Acad Sci USA 109:14241–14246Google Scholar
  64. 64.
    Hadj-Rabia S, Brideau G, Al-Sarraj Y, Maroun RC, Figueres ML, Leclerc-Mercier S, Olinger E, Baron S, Chaussain C, Nochy D, Taha RZ, Knebelmann B, Joshi V, Curmi PA, Kambouris M, Vargas-Poussou R, Bodemer C, Devuyst O, Houillier P, El-Shanti H (2018) Multiplex epithelium dysfunction due to CLDN10 mutation: the HELIX syndrome. Genet Med 20:190–201Google Scholar
  65. 65.
    Bongers EMHF, Shelton LM, Milatz S, Verkaart S, Bech AP, Schoots J, Cornelissen EAM,| Bleich M, Hoenderop JGJ, Wetzels JFM, Lugtenberg D, Nijenhuis T (2017) A novel hypokalemic-alkalotic salt-losing tubulopathy in patients with CLDN10 mutations. J Am Soc Nephrol 28:3118–3312Google Scholar
  66. 66.
    Chikatsu N, Fukumoto S, Takeuchi Y, Suzawa M, Obara T, Matsumoto T, Fujita T (2000) Cloning and characterization of two promoters for the human calcium-sensing Receptor (CaSR) and changes of CaSR expression in parathyroid adenomas. J Biol Chem 275:7553–7557Google Scholar
  67. 67.
    Alam M, Kirton JP, Wilkinson FL, Towers E, Sinha S, Rouhi M, Vizard TN, Sage AP, Martin D, Ward DT, Alexander MY, Riccardi D, Canfield AE (2008) Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cells. Cardiovasc Res 81:260–268Google Scholar
  68. 68.
    Henaut L, Boudot C, Massy ZA, Lopez-Fernandez I, Dupont S, Mary A, Drueke T, Kamel S, Brazier M, Mentaverri R (2014) Calcimimetics increase CaSR expression and reduce mineralization in vascular smooth muscle cells: mechanisms of action. Cardiovasc Res 101:256–265Google Scholar
  69. 69.
    Alesutana I, Tuffaha R, Auer T, Fegera M, Pieske B, Langa F, Voelk J (2017) Inhibition of osteo/chondrogenic transformation of vascular smooth muscle cells by MgCl2 via calcium-sensing receptor. J Hypertens 35:523–532Google Scholar
  70. 70.
    Ferraro PM, Taylor EN, Eisner BH, Gambaro G, Rimm EB, Mukamal KJ, Curhan GC (2013) History of kidney stones and the risk of coronary heart disease. JAMA 310:408–415Google Scholar
  71. 71.
    Domingos F, Serra A (2011) Nephrolithiasis is associated with an increased prevalence of cardiovascular disease. Nephrol Dial Transpl 26:864–868Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Nephrology and Dialysis Unit, Postgraduate School of Nephrology, IRCCS San Raffaele Scientific InstituteVita Salute UniversityMilanItaly

Personalised recommendations